NASDAQ / LIVE COMPANY INTELLIGENCE

MBX Biosciences, Inc.

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERMBX
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / MBX COVERAGE

What’s moving MBX Biosciences, Inc. now

Current reporting with the operating signal separated from the noise.

01
Traders Union

MBX Biosciences, Inc. opens recruitment drive for precision peptide therapies in obesity and hypoparathyroidism

The story matters when it changes MBX Biosciences, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
02
MarketBeat

Swiss National Bank Invests $1.32 Million in MBX Biosciences, Inc. $MBX

The story matters when it changes MBX Biosciences, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
03
MarketBeat

MBX Biosciences, Inc. $MBX Shares Purchased by Stempoint Capital LP

Investors are testing whether MBX Biosciences, Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
04
MarketBeat

MBX Biosciences, Inc. (NASDAQ:MBX) Receives Average Rating of "Moderate Buy" from Analysts

The story matters when it changes MBX Biosciences, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
05
MarketBeat

EcoR1 Capital LLC Decreases Stock Position in MBX Biosciences, Inc. $MBX

Investors are testing whether MBX Biosciences, Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
PRIMARY DOCUMENTS / SEC EDGAR

Latest MBX filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

10-QQuarterly financial reportFiled 2026-05-07 · Period 2026-03-31SEC ↗10-QQuarterly financial reportFiled 2025-11-06 · Period 2025-09-30SEC ↗10-KAnnual financial reportFiled 2026-03-12 · Period 2025-12-31SEC ↗8-KMaterial company eventFiled 2026-07-13 · Period 2026-07-09SEC ↗8-KMaterial company eventFiled 2026-06-12 · Period 2026-06-12SEC ↗8-KMaterial company eventFiled 2026-06-05 · Period 2026-06-04SEC ↗DEF 14AProxy and shareholder meetingFiled 2026-04-22 · Period 2026-04-22SEC ↗SCHEDULE 13GOfficial SEC filingFiled 2026-07-29SEC ↗
EARNINGS / QUARTERLY TRACKER

MBX Biosciences, Inc., quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.